# Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia

> **NCT03784365** · PHASE3 · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 40 (estimated)

## Conditions studied

- Achalasia Cardia

## Interventions

- **DRUG:** One dose of Cefo-perazone Sulbactum

## Key facts

- **NCT ID:** NCT03784365
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2020-02
- **Final completion:** 2020-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03784365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03784365, "Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03784365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*